1. Jemal A, Bray F, Ferlay J. Glob Cancer Stat. 2011;61(2):69–90.
2. American Cancer Society Facts & Figs. 2013, Atlanta GA. 2013
3. Wang K, Wu X, Wang J, Huang J. Cancer stem cell theory: therapeutic implications for nanomedicine. Int J Nanomedicine [Internet]. 2013;8:899–908. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3589204&tool=pmcentrez&rendertype=abstract .
4. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer [Internet]. 2002;2(1):48–58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11902585 .
5. Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Advances in Brief The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) E. 2002;2:22–8